Glycosmedia - an international diabetes news service from the UK
  
 
Archived News
October 21st 2008
 
 
  Diabetes growth doubles in a year
  The number of people diagnosed with diabetes in the UK has risen by more than 167,000 since last year, bringing the total diabetes population to almost 2.5 million according to new data from GP practices (Diabetes UK)
   
  New Guidelines set to help improve services for adults with diabetes
  Health Minister Edwina Hart has today unveiled new guidelines that form part of a delivery strategy for the management of adults with diabetes in Wales (Welsh Assembly Government, UK)
   
  Screening for type 2 diabetes: A randomised controlled trial in British general practice
  Screening for type 2 diabetes in primary care is feasible but may be associated with higher levels of short-term anxiety among invited compared with non-invited participants (BMC Public Health)
   
  Surgery offers best diabetes care in the country
  The practice has received an award from Health Secretary Alan Johnson after scoring the highest marks nationally for its service (Salisbury Journal, UK)
   
  Improved survival in both men and women with diabetes between 1980 and 2004 - a cohort study in Sweden
  Survival rates have improved in subjects with diabetes since the early 1980s, more so in women than in men, thereby decreasing the gap to non-diabetic women (Cardiovascular Diabetology )
   
  Relationship between beta-cell mass and diabetes onset
  The relative contribution of beta-cell loss versus beta-cell dysfunction to diabetes onset remains an area of controversy. However, because cytotoxicity sufficient to induce beta-cell apoptosis predictably disturbs beta-cell function, it is naive to attempt to distinguish the relative contributions of these linked processes to diabetes onset (PubMed)
   
  High levels of adiponectin reduce the risk of type 2 diabetes in women
  Elevated concentrations of total and high-molecular-weight adiponectin inversely and strongly correlated with a substantially reduced risk for diabetes (American Diabetes Association)
   
  Daily drug helps diabetes patients
  Patients given a daily dose of liraglutide, a human GLP-1 analogue, achieved better blood glucose control than those treated with exenatide, a GLP-1 mimetic administered twice daily (Pharmacy Europe)
   
 
  
© Copyright 2008 Glycosmedia Partnership